Hal Barron, Director at Juno Therapeutics, Inc. (JUNO), bought 100,000 shares at $24.00 ($2.4M) on 2014-12-23, disclosed to the SEC on 2014-12-23.
Open-market purchase of $2.4M JUNO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.